🇺🇸 Insulin Glargine 100U/mL in United States
4 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 4
Most-reported reactions
- Death — 1 report (25%)
- Pruritus — 1 report (25%)
- Renal Tubular Acidosis — 1 report (25%)
- Skin Abrasion — 1 report (25%)
Other Diabetes approved in United States
Frequently asked questions
Is Insulin Glargine 100U/mL approved in United States?
Insulin Glargine 100U/mL does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Insulin Glargine 100U/mL in United States?
Novo Nordisk A/S is the originator. The local marketing authorisation holder may differ — check the official source linked above.